메뉴 건너뛰기




Volumn 48, Issue 1, 2001, Pages 53-61

Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients

Author keywords

Ifosfamide; Ifosfamide metabolites; Population pharmacokinetics; Small cell lung cancer

Indexed keywords

2 DECHLOROETHYLIFOSFAMIDE; 3 DECHLOROETHYLIFOSFAMIDE; 4 HYDROXYIFOSFAMIDE; CARBOPLATIN; IFOSFAMIDE; MESNA; PACLITAXEL; UNCLASSIFIED DRUG;

EID: 0034913424     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800100277     Document Type: Article
Times cited : (9)

References (23)
  • 11
    • 0023610106 scopus 로고
    • A randomized comparison of high-dose versus standard-dose cyclophosphamide, doxorubicin and vincristine for extensive small-cell lung cancer. A phase III trial of the Southern Cancer Study Group
    • (1987) J Clin Oncol , vol.11 , pp. 1731-1738
    • Johnson, D.H.1    Einhorn, L.H.2    Birch, R.3
  • 23
    • 0031706550 scopus 로고    scopus 로고
    • High-dose ifosfamide for soft tissue sarcomas: Set the scene, or senescence?
    • (1998) Ann Oncol , vol.9 , pp. 807-809
    • Verweij, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.